Displaying agenda in the event’s time zone (CET, GMT +2)

Thursday, 1 July, 2021
Friday, 2 July, 2021

Pre-Conference Masterclass: Best Practices to Create / Write Effective and Impactful CI Reports and Presentations

An “art” and “science” exists when considering clear, concise and actionable competitive strategy report writing in the biopharmaceutical space.

Many biopharma CI reports disseminated by the Agency are overly verbose, high-level and lack the substantive actionability required for internal usage – facilitating a seamless cascade to management & leadership.

Today’s workshop will translate classical stylistic business writing techniques including those of Strunk and White to the 21st-century biopharmaceutical CI and Strategy world.

In this workshop, we will facilitate two (2) breakouts during which “raw intelligence learnings” will be synthesized and translated into actionable CI deliverables using PowerPoint writing skills and infographic design techniques.

This Workshop is facilitated by David Alderman, President of Molekule Consulting, a global competitive intelligence and strategy consultancy dedicated to the life sciences and biopharmaceutical verticals. David has deep experience from early-development to late-lifecycle management and beyond within biopharma across the competitive landscape among myriad therapy areas, players and subject matters. David is a Subject Matter Expert on the biopharmaceutical vertical; with a particular focus on competition within branded biopharma, small molecule generics and biosimilars.

Presented by Molekule Consulting

Chairpersons’ Opening Remarks

Presented by Novartis

How to Build a Successful and Sustainable CI Function

Daniel will share with the audience his learnings and experiences in building and leading successfully several CI teams over a time span of more than 20 years in the industry.

Topics we will cover:
• What are the 10 “commandments” to build a successful CI team
• What is needed to make the CI team relevant and impactful for a company
• How to recruit the best CI talent into the department and retain them
The audience can expect to be able to participate actively in the “conversation” and contribute to the program

Presented by Molekule Consulting

The Strategic Value of Generic & Biosimilar CI In Life Sciences

This session will provide insights and highlight best practices to enable LLCM value and asset maximization by leveraging a number of tools unique to CI professionals. Specifically this presentation will enable you to:

* Advance your understanding of core Gx/biosimilar market dynamics and corresponding CI solutions
* Set up a best-in-industry Gx/biosimilar regulatory intelligence (RI) and CI tracking program
* Understand Gx / biosimilar product development and entry strategies
* Identify potential actions to optimize launches

Presented by INOVIS



CI Across the Pharmaceutical Value Chain: Challenges, Opportunities and Learnings

Presented by Astrazeneca

The Forgotten Pharma CI Corner; Cost of Goods (COGs) Intelligence

With the CAR-T and gene therapy revolutions, biosimilar /biobetter challenges to long established biologic innovators and a surge in vaccine innovation, manufacturing and supply chain intelligence is rising in its importance.

In 2014 Dig Worldwide developed and introduced COGIntel a quick, robust and cost effective COGs benchmarking solution.
Technical Cost Modelling (TCM) , a method developed at MIT in the 1980’s has long been the gold standard in benchmarking cost-of-goods sold which is time and resource intensive with a limited shelf-life. Although not as precise as TCM, Dig Worldwide’s bespoke COGIntel method allows rapid and cost effective COG benchmarking analysis that provides “good enough” competitive intelligence for strategic decision making. Performance gaps and areas of advantage or disadvantage become visible verses forgotten.
An illustrative CAR-T case study will form an integral part of the talk to help illustrate Dig Worldwide’s methodology.

Presented by Dig Worldwide

Adapting Predictive Analytics in an Organization to Gain Competitive Edge

Presented by Lonza


Pharma in the AI Era: How Advancements in Research Are Impacting CI Professionals

The Future of AI is here and rapidly advancing through many facets of the pharma sector.

From target identification and drug development to patient diagnosis and even to patient care, CI professionals need to be able to keep up with the increasing pace of business and ever-expanding competitive landscape. Through advancements in research, CI professionals can better understand the vast amount of patient, research, and diagnostic data to make better investment decisions.

Join this session to learn:
• How to leverage the building blocks of Natural Language Processing and Machine learning to drive forward offerings in Sentiment Analysis, thematic and KPI extraction, and enterprise knowledge management
• How these technologies are already impacting the pharma professional’s day-to-day
• How advancements in AI will impact the pharma industry long term and may reshape the duties of a Competitive Intelligence team

Presented by AlphaSense

Business Case – When to Prepare It, What Shall Be In, What Is the Impact of CI and MR on Business Case Outcome and How to Communicate It to Decision Makers

Presented by Tillotts Pharma

Real-time Intelligence and Advanced Visualization in the World of Competitive Intelligence

This session is intended for pharma, biotech and medical device stakeholders who can be benefited by:

1. Evaluating physicians brand perception, usage, adoption of a recently launched product
2. Analyzing patient brand usage, social media listening for efficacy, side effects & cost

Strategic use of real-time intelligence helps decision-makers in 4 ways:
1. Evaluate target product profiles (TPP) for approved and upcoming treatment options
2. Assess unmet medical needs, time to diagnose, treatment journey and treatment switch
3. Analyse patient sentiments for targeted brand versus competitive brands
4. Visualization of unmet medical needs, prescription drivers for target brand and in-depth intelligence on competitors’ brand

Presented by Borderless Access

ROUNDTABLE: More Effectively Collaborate With Your Colleagues and Agencies to Drive Enhanced CI and Business Planning at Your Company

Presented by Bayer

One-On-One Meetings

Pre-Conference Masterclass: Developing a Competitive Activity Framework to Enhance Organizational Competitiveness

This workshop session will give participants first-hand insights from a combined 30+ years of experience in delivering strategic and tactical workshop-style solutions, using an optimal blend of established CI frameworks alongside INOVIS’ in-house proprietary methodologies.

Key to this session will be addressing business needs across the lifecycle, whereby participants will:

* Develop an in-depth understanding of how a diverse range of facilitated activities (Rapid Immersion, Threat Assessment and Competitor Simulations) can help deliver strategic and competitive insights within an organization
* Appreciate the importance of leveraging the outcomes of workshops to inform and direct decision making
* Receive hands-on opportunities to apply learnings to a pharma case-study in a learning environment
Using business case studies, real-life experiences and validated theory, the INOVIS team will equip you with a number of go-to techniques that can be rapidly integrated into ongoing CI Practice, whether you’re a seasoned CI professional veteran, or newer to the field.

Presented by INOVIS

Welcome and Re-Cap of Day One

Presented by Novartis

Megatrends in Healthcare

This talk will discuss the interplay of various factors that are currently influencing the healthcare and pharmaceutical landscapes and the emerging trends that are shaping the new era of healthcare.

How can we use demographic shifts to help inform new business models? How will digital disruption affect drug development and access? How are mHealth platforms shifting patients’ approaches to healthcare?

Presented by Lifescience Dynamics

CI and Execution: Leading High Growth Pharma Brands

“A mediocre strategy well executed is better than a great strategy poorly executed”

Launching a new product is exciting and intense, but transitioning a product from launch to growth requires endurance and deliberation. Furthermore, scaling requires leaders who understand the role of competitive intelligence and how to manage the increased organizational and business complexity of growth.

Having supported numerous blockbuster brands, we have identified three frameworks to help brand leaders achieve high growth. The frameworks are:
• Leading high growth
• Competitive Prioritization Assessment
• Competitive readiness

In this talk, we will introduce the three frameworks. Additionally, we will share how the CI professional can have a greater impact on high-growth brands by shifting focus from strategy to execution.

Presentation attendees will receive a copy of the article “Leading High Growth Ventures” from Harvard Business Publishing. We look forward to seeing you there!

Presented by Atacana Group



When CI goes Global: a 10 Year Journey to Bring Intelligence at Global Level

Presented by Chiesi Farmaceutici S.p.A.

Enriching Pharma CI With Expertly Curated Content and Digital Tools: An ASCO 2021 Case Study

• Data overwhelm challenge pharma teams are facing

• Information management from public domain: sifting through the ‘noise’
• Using the hybrid of technology and human touch to create successful outcomes
• Case study: ASCO2021

Presented by Larvol

Tracking and Reacting to the Changing Landscape of External Innovation

Presented by Limbach Gruppe


Everyday Competitive Intelligence to Solve for Unmet Needs

Life sciences firms must target and address a continuously evolving range of unmet needs in key therapeutic areas.

How can CI practices mixed with artificial intelligence create trained queries & agents that hunt for solutions and problem solvers? How to ensure that all relevant global and internal data is captured?

This session uses the cloud-based machine learning platform to illustrate systematic discovery and predictions of unmet needs solutions & partners – without the burdens of data science.

Presented by Perception Partners

ROUNDTABLE: Beyond “Usual” Intelligence on Medicinal Products: How to Monitor Digital Scenario

Presented by Chiesi Farmaceutici S.p.A.

ROUNDTABLE: Personal Professional Challenges – How to Sell your Analysis Internally

Presented by SOTIO, a.s.

Designing Winning Trials for Reimbursement – Strategic Framework

- Learn HTA reimbursement approval/rejection rates

– Reflect On Key Strategic Elements when designing Ph III

– Tradeoffs between HTA requirements and Clinical Developing Plans

– Main tactics at hand for clinical trial design

Presented by Novartis

One-On-One Meetings